Kither Biotech Doses First Patients in KIT2014 COPD Clinical Trial

KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), non-CF bronch...

September 30, 2026 | Wednesday | News
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
Codexis Partners with siRNA Innovator to Advance Enzymatic Oligonucleotide Manufacturing

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced an agreement with ...

September 30, 2026 | Wednesday | News
Grünenthal and DKSH Expand Asia-Pacific Partnership to Broaden Access to Pain Medicines

Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...

September 29, 2026 | Tuesday | News
InSilicoTrials Joins ARPA-H CIRCLE Project to Advance Digital Twins for Critical Illness

InSilicoTrials, a cloud-based platform for AI and computational modeling and simulation in healthcare, today announced that it is a subawardee on a team ...

September 28, 2026 | Monday | News
RefinedScience Expands Pancreatic Cancer Dataset With Multi-Institutional Sample Access

Marsico Pancreatic Cancer Initiative at CU Anschutz expands across institutions, pairing single-cell and spatial profiles with longitudinal outcomes fr...

September 28, 2026 | Monday | News
Pharming Seeks FDA Approval to Expand Joenja Use to Younger Children With APDS

If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or more Decision follows recent approval ...

September 28, 2026 | Monday | News
Astellas Doses First Patient in Phase 3 Trial of Setidegrasib for KRAS G12D-Mutated Lung Cancer

Astellas Pharma Inc.announced that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-t...

September 25, 2026 | Friday | News
InnoCare Pharma and Eli Lilly Partner to Develop New Medicines Across Five Targets

InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the Company has entered ...

September 25, 2026 | Friday | News
BioArctic’s Leqembi Begins Patient Treatment in Sweden Outside Clinical Study

 BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced  that Leqembi is now available at a private clinic in Sweden and that the first patie...

September 24, 2026 | Thursday | News
NanoImaging Services and Proteos Launch TrueCourse Biosciences to Integrate Drug Discovery Capabilities

NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have  announced the launch of TrueCourse Biosciences, an in...

September 24, 2026 | Thursday | News
Andelyn Biosciences Begins Commercial Manufacturing of FDA-Approved Fayuvi Gene Therapy

Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...

September 23, 2026 | Wednesday | News
FDA Approves AQNEURSA as First Treatment for Ataxia-Telangiectasia

IntraBio Inc., a leader in the discovery, development, and commercialization of novel therapies for rare and common neurodegenerative diseases, announced...

September 22, 2026 | Tuesday | News
Silo Pharma Receives USPTO Notice of Allowance for SPC-15 PTSD Therapeutic

Silo Pharma (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug del...

September 21, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close